Meta-analyses of Fructose-containing Sugars and Incident Cardiometabolic Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Since uncontrolled observational studies first linked fructose to the epidemic of obesity almost a decade ago, it has become a focus of intense concern regarding its role in the obesity epidemic and increasing burden of cardiometabolic disease. Despite the uncertainties in the evidence, international health organizations have cautioned against moderate to high intakes fructose-containing sugars, especially those from sugar sweetened beverages (SSBs). To improve the evidence on which nutrition recommendations are based, the investigators propose to study of the role of fructose-containing sugars in the development of overweight/obesity, diabetes, hypertension, gout, and cardiovascular disease, by undertaking a series of systematic syntheses of the available prospective cohort studies. Prospective cohort studies have the advantage of relating "real world" intakes of sugars to clinically meaningful disease endpoints over long durations of follow-up. The findings generated by this proposed knowledge synthesis will help improve the health of consumers through informing recommendations for the general public, as well as those at risk of diabetes and cardiovascular disease.
| Condition |
|---|
|
Overweight Obesity Dyslipidemia Hyperlipidemia Diabetes Prediabetes Dysglycemia Gout Hypertension Metabolic Syndrome Coronary Heart Disease Cardiovascular Disease |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | The Relation of Fructose-containing Sugars to Incident Cardiometabolic Disease: Systematic Reviews and Meta-analyses of Prospective Observational Studies to Provide Evidence-based Guidance for Nutrition Guidelines Development |
- Overweight/obesity analysis [ Time Frame: up to 1.5-years ] [ Designated as safety issue: No ]Risk ratios for incident Overweight and obesity by total fructose-containing sugar exposure
- Diabetes/metabolic syndrome analysis [ Time Frame: Up to 1.5-years ] [ Designated as safety issue: No ]Risk ratios for incident diabetes and metabolic syndrome by total fructose-containing sugar exposure
- Hypertension analsysis [ Time Frame: Up to 1.5-years ] [ Designated as safety issue: No ]Risk ratios for incident hypertension by total fructose-containing sugar exposure
- Gout analysis [ Time Frame: Up to 1.5-years ] [ Designated as safety issue: No ]Risk ratios for incident gout by total fructose-containing sugar exposure
- Coronary heart disease (CHD) analysis [ Time Frame: Up to 1.5-years ] [ Designated as safety issue: No ]Risk ratios for incident CHD by total fructose-containing sugar exposure
| Estimated Enrollment: | 1 |
| Study Start Date: | May 2012 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |
Show Detailed Description
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Varied
Inclusion Criteria:
- Prospective observational studies
- Assessment of fructose-containing sugar exposure
- Viable clinical outcome data by level of exposure
Exclusion Criteria:
- Ecological, cross-sectional, and retrospective observational studies, clinical trials, and non-human studies
- No assessment of fructose-containing sugar exposure
- No viable clinical outcome data by level of exposure
Contacts and Locations| Canada, Ontario | |
| The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital | |
| Toronto, Ontario, Canada, M5C 2T2 | |
| Study Director: | John L Sievenpiper, MD, PhD | Department of Pathology and Molecular Medicine, McMaster University and Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital |
| Study Director: | Russell J de Souza, ScD, RD | Department of Epidemiology and Biostatistics, McMaster University and Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital |
| Principal Investigator: | David JA Jenkins, MD, PhD, DSc | Department of Nutritional Sciences and Medicine, University of Toronto and Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital |
More Information
Publications:
| Responsible Party: | John Sievenpiper, Adjunct Research Fellow, University of Toronto |
| ClinicalTrials.gov Identifier: | NCT01608620 History of Changes |
| Other Study ID Numbers: | CCC 2012 KRS EPI |
| Study First Received: | May 28, 2012 |
| Last Updated: | August 24, 2012 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by University of Toronto:
|
Systematic review and meta-analysis Evidence-based medicine (EBM) Evidence-based nutrition (EBN) Clinical practice guidelines Clinical trials Dietary sugars Fructose High fructose corn syrup Fruit Isocaloric |
Hypercaloric Cardiometabolic risk factors Triglycerides Cholesterol Glycemic control Insulin resistance Body weight Uric acid Blood pressure |
Additional relevant MeSH terms:
|
Cardiovascular Diseases Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases Hyperlipidemias Hypertension Obesity Dyslipidemias Glucose Intolerance Prediabetic State Overweight Metabolic Syndrome X Arteriosclerosis |
Arterial Occlusive Diseases Vascular Diseases Lipid Metabolism Disorders Metabolic Diseases Overnutrition Nutrition Disorders Body Weight Signs and Symptoms Hyperglycemia Glucose Metabolism Disorders Diabetes Mellitus Endocrine System Diseases Insulin Resistance Hyperinsulinism |
ClinicalTrials.gov processed this record on May 16, 2013